The short version
The human trial summarized below tested intravenous ipamorelin after bowel surgery. Its results need to be read in that clinical setting and route.
An investigational profile is not an endorsement or a finding of safety.
Names you may see
Compound names, research identifiers, brand names and informal shorthand serve different purposes.
- Ipamorelin
- Entry name · The name used for this encyclopedia topic.
- Ipamorelin acetate
- Recorded name variation · A name associated with this entry; check exact ingredient, modification, formulation and context.
Similar names do not establish identical ingredients, molecular variants, product quality or interchangeable preparations. A blend nickname may describe different formulas.
Things worth checking
Was the human study testing the use I have in mind?
The selected trial used intravenous treatment after bowel surgery. It did not test muscle gain or athletic recovery. Ask what evidence, if any, addresses the actual goal, preparation and route being proposed.
Study-specific context · Original postoperative bowel-recovery study ↗
Questions to bring to a clinician or pharmacist
- Which findings apply to my goal and medical history?
- Could my medicines, supplements, or other compounds change the assessment?
- What monitoring, if any, would inform a decision—and what symptoms would need evaluation?
Monitoring is individual. Normal bloodwork does not establish that a compound or preparation is safe.
Clinical research
A selected human trial is available, but it does not establish benefit for the body-composition or athletic uses readers may encounter.
Bowel recovery after surgery (2014)
Summary based on: Published abstract
- Study design
- Multicenter, randomized, double-blind, placebo-controlled phase 2 study.
- Who was studied
- 117 adults enrolled after bowel resection; 114 were included in safety and modified intention-to-treat analyses.
- Route and preparation
- Intravenous infusion in hospitalized surgical patients.
- What was compared
- Intravenous ipamorelin versus placebo for up to seven postoperative days or hospital discharge.
- What researchers found
- Median time to tolerating a meal was 25.3 hours with ipamorelin versus 32.6 hours with placebo (p=0.15). The key and secondary efficacy analyses did not show significant differences.
- What this leaves unanswered
- The study was small and involved varied underlying conditions. It does not establish improved gym recovery, muscle gain, or safety for a different injection route.
Research terms in everyday language ↗
Selected original-study summary; broader literature review, full safety extraction and editorial sign-off are pending.
Read findings in the context of the exact product or preparation, the people studied, and the outcome measured. These draft profiles are starting points, rather than complete systematic reviews.
Community research
Structured community reports can help identify questions worth studying. They are considered separately from controlled studies, with their limitations kept visible.
No community reports published yet.
This profile has no published community dataset. We do not infer a trend or a benefit from missing reports.
How community research will work ↗What we will document about community advice
- The advice
- What people recommend, with dated sources and the scope of the discussions examined.
- The reasoning
- Why contributors believe it helps, without treating that explanation as an established mechanism.
- The evidence
- What supports the claim, contradicts it, or has not been tested.
- The cautions
- Possible downsides, conflicting experiences, and questions for a clinician or pharmacist.
No recommendation or community consensus is established by this framework. Descriptions of how common advice is will need documented source coverage.
A closer look
- Classification
- Ghrelin-receptor agonist
- Name variations
- Names you may see and important distinctions
- Source type
- Regulatory safety notice
- Reference jurisdiction
- United States
Interpret the source in the context of the preparation and route it discusses. A regulatory notice and a controlled clinical trial answer different questions.
This first design edition reserves space for study-by-study summaries, definitions, and technical references as each profile receives editorial review.
Go to the source
Study cards identify whether the summary uses an abstract, full text, or an agency assessment. Follow the linked sources for their original context.
Source reference · Checked 7 November 2026 · Opens in a new tab
For athletes: competition rules are a separate check ↗